Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] ...

Lightcast, a pioneering life science tools company, today announced the appointment of Philip Binns as chairman of its board of directors, effective May 1, 2025. With this appointment, the Lightcast ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Data does not support claims that the United States is experiencing a surge in crime caused by immigrants. In the past few months, politicians and certain media outlets have latched on to a narrative ...

Below, we’ll dive deeper into what makes these casinos the best options for Australian players. Choosing the very best online gambling sites can be overwhelming, with so many options available.

Sixty-two articles were included in the final analysis. We assessed studies for risk of bias and quality of evidence. The majority of studies (84%) were from North America or Europe, and conducted in ...

A new equation, developed using data from an IAEA nutrition database, is helping researchers assess the accuracy of self-reported dietary information in studies and surveys ... a professor at the ...

We searched PubMed between Jan 1, 1980, and Oct 22, 2023, to identify studies that assessed trends in nervous system health loss globally, with the search string (“nervous system”[Title] OR ...

The government has unveiled legislation to amalgamate four of the country’s main tertiary schools into one entity—the Antigua and Barbuda College of Advanced Studies. The legislation ...

Date: June 14 from 10.00 am to 7.00 p.m. Glion Institute of Higher Education invites applications to its Executive Master of Advanced Studies in Hospitality and Business Leadership beginning in ...

Ishita has previously contributed to a number of publications, including The Indian Express, The Logical Indian, and Feminism In India. She has over two years of writing experience and enjoys ...

French-Spanish director Óliver Laxe makes his debut in the Cannes Film Festival Competition with a film that arguably would be better placed in one of the festival’s Midnight slots. Part ...